Core Insights - The company, 麦澜德, closed at 29.24 yuan on May 6, with a 2.78% increase, and a rolling PE ratio of 27.81, marking a new low in 21 days, with a total market capitalization of 2.924 billion yuan [1][2] - In the medical device industry, the average PE ratio is 48.90, with a median of 36.41, placing 麦澜德 at the 64th position [1][2] - As of March 31, 2025, 麦澜德 had 4,927 shareholders, an increase of 433, with an average holding value of 352,800 yuan and an average holding of 27,600 shares [1] Company Overview - 麦澜德 specializes in the research, production, sales, and services of products related to pelvic floor and obstetric rehabilitation, focusing on female pelvic floor and obstetric rehabilitation [1] - The main products include pelvic floor and obstetric rehabilitation products, reproductive rehabilitation products, sports rehabilitation products, consumables, and information technology products [1] - 麦澜德 has been recognized as a "national manufacturing single champion" by the Ministry of Industry and Information Technology, reflecting its specialization, innovation capability, management level, market competitiveness, and social benefits in the field of pelvic floor and obstetric rehabilitation [1] Financial Performance - In the first quarter of 2025, the company reported revenue of 118 million yuan, a year-on-year increase of 13.36%, and a net profit of 39.86 million yuan, up 9.85%, with a gross profit margin of 70.85% [2] - The company's PE ratio (TTM) is 27.81, while the industry average is 48.90, indicating a lower valuation compared to peers [2]

浙江夏厦精密制造股份有限公司 ZHEJIANGXIASHAPRECISIONMANUFACTURINGCO.,LTD. （浙江省宁波市镇海区骆驼工业小区荣吉路） 首次公开发行股票并在主板上市 招股说明书 （申报稿） 保荐机构（主承销商） （浙江省杭州市西湖区天目山路 198 号财通双冠大厦西楼） 浙江夏厦精密制造股份有限公司 招股说明书（申报稿） 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对注册 申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行 人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任何与之 相反的声明均属虚假不实陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由发 行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承 担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 浙江夏厦精密制造股份有限公司 招股说明书（申报稿） 本次发行概况 | 发行股票类型 | 人民币普通股（A 股） | | --- | --- | | 发行股数，股东公开发售 | 本次拟向社会公众公开发行股 ...